A Phase 3 open-label study of Infacort in neonates, infants and children less than 6 years of age with adrenal insufficiency.
Phase of Trial: Phase III
Latest Information Update: 20 May 2017
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Congenital adrenal hyperplasia
- Focus Therapeutic Use
- Sponsors Diurnal
- 18 Jun 2016 Status changed from recruiting to completed.
- 04 Mar 2015 New trial record